Evidence-based approach to treatment of myelodysplastic syndromes

Haematologica

Volumn 86, Issue 9, 2001, Pages 897-899

  Bernasconi, C ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; AMIFOSTINE; ANGIOGENESIS INHIBITOR; AZACITIDINE; CYTARABINE; CYTOKINE ANTIBODY; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT; PENTOXIFYLLINE; PYRIMIDINE DERIVATIVE; THALIDOMIDE;

ALGORITHM; DIAGNOSTIC PROCEDURE; EDITORIAL; EVIDENCE BASED MEDICINE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ITALY; MYELODYSPLASTIC SYNDROME; PRACTICE GUIDELINE; REGISTER; STEM CELL TRANSPLANTATION; TREATMENT PLANNING;

CLINICAL PROTOCOLS; DECISION TREES; EVIDENCE-BASED MEDICINE; HUMANS; ITALY; MYELODYSPLASTIC SYNDROMES; REGISTRIES;

EID: 0034791950     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (6)

1. Gli obiettivi del registro italiano delle sindromi mielodisplastiche
2. Proposal for the classification of the myelodysplastic syndromes
3. International scoring system for evaluating prognosis in myelodysplastic syndromes
4. Report of an international working group to standardize response criteria for myelodysplastic syndromes
5. Management of myelodysplastic syndromes
6. High-dose therapy for myelodysplasia